Microalbuminuria

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2010-12-10
Clinical Trial Update: Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors [Phase 3]
A Phase 3 trial evaluating the impact of rimonabant on regression of asymptomatic cardiovascular damage was terminated.